SU105264A1 - Method of treating coronary insufficiency - Google Patents

Method of treating coronary insufficiency

Info

Publication number
SU105264A1
SU105264A1 SU555690A SU555690A SU105264A1 SU 105264 A1 SU105264 A1 SU 105264A1 SU 555690 A SU555690 A SU 555690A SU 555690 A SU555690 A SU 555690A SU 105264 A1 SU105264 A1 SU 105264A1
Authority
SU
USSR - Soviet Union
Prior art keywords
coronary insufficiency
treating coronary
daukarin
drug
insufficiency
Prior art date
Application number
SU555690A
Other languages
Russian (ru)
Inventor
М.А. Ангарская
М.А. Ангарска
А.А. Дубинский
Д.Г. Колесников
А.П. Прокопенко
Я.И. Хаджай
М.И. Шубов
Original Assignee
М.А. Ангарская
М.А. Ангарска
А.А. Дубинский
Д.Г. Колесников
А.П. Прокопенко
Я.И. Хаджай
М.И. Шубов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by М.А. Ангарская, М.А. Ангарска, А.А. Дубинский, Д.Г. Колесников, А.П. Прокопенко, Я.И. Хаджай, М.И. Шубов filed Critical М.А. Ангарская
Priority to SU555690A priority Critical patent/SU105264A1/en
Application granted granted Critical
Publication of SU105264A1 publication Critical patent/SU105264A1/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Description

Известны способы лечени  коронарной недостаточности с помощью ннтро1 тицерина, амил-нитрита. валидола и других лекарственных средств, оказывающих кратковременное действие.Methods are known for treating coronary insufficiency with nitrocytin, amyl nitrite. validol and other drugs that have a short-term effect.

Предлагаетс  способ .лечени  коронарной недостаточности нрепаратом даукарнн, оказывающим более длите.тьноесосудораспп-1р ющееA method is proposed for treating coronary insufficiency by the preparation Daucarnn, which has a longer duration of the vessel.

дейстр.ие, чем перечисленные лекарства .action than listed drugs.

Препарат даукарин нрсдставл ет из себ  суммарный очищенный экстракт из сем н моркови огородной Daycus Sativus (ПоЬт) Rochl (семейство зонтичных) и относнтс  к веществам сназмо.читического де11стви . Он обладает способностью расщир ть коронарные сосуды сердца и нримен етс  дл  лечени  коронарной недостаточности.The preparation daukarin is derived from the total purified extract from carrot seeds of the Daycus sativus (Pocht) Rochl (family of umbrella) carrots from the garden plant and relates to the substances of sleep pseudopathy. It has the ability to dilate the coronary vessels of the heart and is used to treat coronary insufficiency.

Даукарин не обрывает уже зозникншй Приступ стенокардии, так как терапевтический эффект наступает через 3-5 дней после начала приема препарата.Daukarin does not interrupt the already active attack of angina, as the therapeutic effect occurs 3-5 days after the start of taking the drug.

Выпускаетс  в виде таблеток весомAvailable in pill weight.

0,1 с с содержанием даукарина 0,02 г. Назначаетс  внутрь по 1 таб.тетке (по 0,02 г) :-т 3 до 5 р;:; в день за 30 мннут до еды.0.1 s with a daukarin content of 0.02 g. It is administered orally on 1 tablet (0.02 g each): -t 3 to 5 r;:; per day for 30 minutes before meals.

Длнтельпость леченн  от двух до четырех недель.Long-term treatment is from two to four weeks.

Протипоказани к применению препарата не установлено.Protypes to the use of the drug is not installed.

Пренарат даукарин разреи е} к применению в медицпнсхо ; практике Фармакологическим комитетом Ученого Совета Министерства здравоохраненн  СССР.Prenarate Daukarin resolution e} for use in medicine; the practice of the Pharmacological Committee of the Scientific Council of the Ministry of Health of the USSR.

Предмет и з о б р с т е н и  Subject and B about with with and N and

Claims (2)

1.Способ .течени  ко1юнарно11 недоетаточности , о т л и чаю щ и и с   тем, что дл  этой примен ют прен рат далкарин. получаемы нз сем н морковн огородной Dayens Sativus (Hoffm) Roelil.1. A method for coping with 11 deficiencies, which means that dalcarin is used for this. are obtained from the seeds of the carrot garden Dayens Sativus (Hoffm) Roelil. 2.Прием выполнени  способа по п. 1, от л и ч а ю щ н i; с   тем, что препарат даукарин назначаетс  внутрь по 0,02 г от трех до п ти раз в день за 30 Минут до еды, в продолжение от двух до четырех недель.2. Acceptance of the method according to claim 1, dated l i; so that the drug daukarin is administered orally at 0.02 g from three to five times a day 30 minutes before a meal, lasting from two to four weeks.
SU555690A 1956-08-02 1956-08-02 Method of treating coronary insufficiency SU105264A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU555690A SU105264A1 (en) 1956-08-02 1956-08-02 Method of treating coronary insufficiency

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU555690A SU105264A1 (en) 1956-08-02 1956-08-02 Method of treating coronary insufficiency

Publications (1)

Publication Number Publication Date
SU105264A1 true SU105264A1 (en) 1956-11-30

Family

ID=48378681

Family Applications (1)

Application Number Title Priority Date Filing Date
SU555690A SU105264A1 (en) 1956-08-02 1956-08-02 Method of treating coronary insufficiency

Country Status (1)

Country Link
SU (1) SU105264A1 (en)

Similar Documents

Publication Publication Date Title
Betz et al. The relationship of the therapist to the outcome of therapy in schizophrenia.
SU105264A1 (en) Method of treating coronary insufficiency
GB1157717A (en) Method and Apparatus for Processing Garlic
MAY et al. Parkinsonian reactions following chlorpromazine and reserpine: Similar reactions in the same patients
Pecknold et al. Lack of indication for use of antiparkinson medication: A follow-up study.
Holdway Trial of imipramine
Dallas Penicillin treatment failures in male gonorrhoea
Keeton et al. Dramatic respiratory symptoms induced by sudden withdrawal of ACTH
RU2582282C1 (en) Method of producing agent having stress protective and anti-hypoxic activity
SU114346A1 (en) Method of treating gallstone disease in humans
FUJIHIRA On the treatment of eight cases of valvular disease of the heart
SU94959A1 (en) A method of treating hypertension with liver drug "antisimpatin"
SU135426A1 (en) Drug olitorizid
Haessler et al. H. Clinical, bacteriologic and serologic data in leptospiral uveitis. Arch. f. Ophth.
FR1056M (en) Pharmaceutical product intended for the treatment of circulatory disorders of the upper or lower limbs.
Chamberlain et al. Clinical experience with the oral administration of cedilanid, and a comparison of the oral and intravenous preparations of cedilanid with digitalis purpurea
SU110654A1 (en) A method for the treatment of diseases accompanied by spasms of smooth muscle organs
SU98807A1 (en) Method of treating diseases of the central nervous system
ZAKON et al. Introduction of quinacrine in treatment of lupus erythematosus
SU148758A1 (en) The way to standardize heart remedies
Kline et al. EFFECTS OF ANTIBIOTICS ON MUSCLE-NERVE REACTIONS OF FROGS
Aaron IONTOPHORESIS OF PYRIBENZAMINE
Lundholm The growth of the psychological self:(I) Character.
Davletkildeeva Materials on the use of adrenocorticotropic hormone and cortisone in clinics of 6 internal diseases
LEWiS Diuresis and the caffein group of diuretics